HK Stock Market Move | HYGEIA HEALTH (06078) rose by 10% once and launched a 1.5 billion yuan shareholder return plan. Outpatient visits increased by 4% in the first five months of this year.
Haijia Medical (06078) surged more than 10% at one point, and as of the time of writing, it has risen by 8.09% to reach HK$8.82, with a transaction volume of HK$33.94 million.
HYGEIA HEALTH (06078) rose more than 10% at one point, and as of press time, it has risen by 8.09% to HKD 8.82, with a turnover of HKD 339.41 million.
On the news front, on the evening of June 17, HYGEIA HEALTH announced that the board of directors has approved a shareholder return plan covering the three fiscal years from 2026 to 2028. According to the shareholder return plan, the company plans to utilize approximately RMB 500 million each year within the three fiscal years ending on December 31, 2028, to provide returns to shareholders through share buybacks and/or dividends, to be determined at the discretion of the board of directors.
In addition, HYGEIA HEALTH disclosed that for the five months ending on May 31, 2026, the group had approximately 1.453 million outpatient visits, a year-on-year increase of 4.0%, and performed around 38,000 surgeries, a year-on-year increase of 7.6%, with 18,000 of them being major surgeries, representing a 15.2% year-on-year increase. Since the second half of last year, the group's international medical business has been growing rapidly, with several hospitals under its umbrella expanding their international medical services.
Related Articles

HK Stock Market Move | CSTONE PHARMA-B (02616) rose by more than 5% since June, with multiple directors increasing their holdings. CS5007 global clinical development has been fully launched.

HK Stock Market Move | DOBOT (02432) has risen more than 5%. It was announced recently that the next generation of interactive AI humanoid companion, Siasun Robot & Automation, will soon be released.

HK Stock Market Move | INSILICO (03696) rises more than 6% against the market trend. The Phase III clinical conference of Rentosertib is held, verifying the AI research and development capabilities once again.
HK Stock Market Move | CSTONE PHARMA-B (02616) rose by more than 5% since June, with multiple directors increasing their holdings. CS5007 global clinical development has been fully launched.

HK Stock Market Move | DOBOT (02432) has risen more than 5%. It was announced recently that the next generation of interactive AI humanoid companion, Siasun Robot & Automation, will soon be released.

HK Stock Market Move | INSILICO (03696) rises more than 6% against the market trend. The Phase III clinical conference of Rentosertib is held, verifying the AI research and development capabilities once again.

RECOMMEND





